Manisha H. Shah

Research interests

Publications

• Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

  Journal of Clinical Oncology · 2022 · 10.1200/jco.22.01013

• 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

  Thyroid · 2021 · 10.1089/thy.2020.0944

• Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2021 · 10.6004/jnccn.2021.0032

• Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

  The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30445-9

• Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2005653

• Efficacy of Selpercatinib in RET -Altered Thyroid Cancers

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2005651

• A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

  Clinical Cancer Research · 2020 · https://doi.org/10.1158/1078-0432.ccr-19-3356

• Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

  Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.02105

• NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018

  Journal of the National Comprehensive Cancer Network · 2018 · 10.6004/jnccn.2018.0056

• Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx479

• Neuroendocrine Tumors, Version 1.2015

  Journal of the National Comprehensive Cancer Network · 2015 · https://doi.org/10.6004/jnccn.2015.0011

• Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

  Thyroid · 2015 · https://doi.org/10.1089/thy.2014.0335

• A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer

  Clinical Cancer Research · 2015 · https://doi.org/10.1158/1078-0432.ccr-15-1127

• A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment

  Cancer · 2015 · https://doi.org/10.1002/cncr.29395

• Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1406470

• Cabozantinib in Progressive Medullary Thyroid Cancer

  Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2012.48.4659

• American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

  Thyroid · 2012 · 10.1089/thy.2012.0302

• Everolimus for Advanced Pancreatic Neuroendocrine Tumors

  New England Journal of Medicine · 2011 · 10.1056/nejmoa1009290

• Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.25.0068

• Neuroendocrine Tumors

  Journal of the National Comprehensive Cancer Network · 2009 · 10.6004/jnccn.2009.0050

• Phase II Trial of Sorafenib in Metastatic Thyroid Cancer

  Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.18.2717

• Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

  Journal of Clinical Oncology · 2009 · 10.1200/jco.2009.24.2669

• Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

  Blood · 2009 · 10.1182/blood-2009-08-231613

• E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer

  Cancer Cell · 2008 · https://doi.org/10.1016/j.ccr.2008.02.013

• Cardiotoxicity of Histone Deacetylase Inhibitor Depsipeptide in Patients with Metastatic Neuroendocrine Tumors

  Clinical Cancer Research · 2006 · 10.1158/1078-0432.ccr-05-2689

• Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

  The Lancet · 2006 · https://doi.org/10.1016/s0140-6736(06)69446-4

• Differential Cytokine and Chemokine Gene Expression by Human NK Cells Following Activation with IL-18 or IL-15 in Combination with IL-12: Implications for the Innate Immune Response

  The Journal of Immunology · 1999 · 10.4049/jimmunol.162.8.4511

Current projects

No projects listed.